Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Apr 23;19(4):3465–3476. doi: 10.1007/s10311-021-01244-5

History of cyclodextrin-based polymers in food and pharmacy: a review

Max Petitjean 1, Iñigo X García-Zubiri 2, José Ramón Isasi 1,✉
PMCID: PMC8062835  PMID: 33907537

Abstract

Cyclodextrins are glucose macrocycles whose inclusional capabilities towards non-polar solutes can be modulated with the help of other macrostructures. The incorporation of cyclodextrin moieties into larger structures produces five types of new materials: crosslinked networks, functionalized chains, amphiphilic cyclodextrins, polyrotaxanes and nanocomposites. This review presents crosslinking and grafting to prepare covalently-attached cyclodextrins, and applications in the food and pharmaceutical sectors, from an historical point of view. In food science, applications include debittering of juices, retention of aromas and release of preservatives from packaging. In biomedical science, cyclodextrin polymers are applied classically to drug release, and more recently to gene delivery and regenerative medicine. The remarkable points are: 1) epichlorohydrin and diisocyanates have been extensively used as crosslinkers since the 1960s, but during the last two decades more complex cyclodextrin polymeric structures have been designed. 2) The evolution of cyclodextrin polymers matches that of macromolecular materials with regard to complexity, functionality and capabilities. 3) The use of cyclodextrin polymers as sorbents in the food sector came first, but smart packaging is now an active challenge. Cyclodextrins have also been recently used to design treatments against the coronavirus disease 2019 (COVID-19).

Keywords: Cyclodextrin polymers, Crosslinking, Drug delivery, Regenerative medicine, Food packaging

Introduction

In addition to their remarkable capability to establish supramolecular host–guest interactions because of their toroidal shape and non-polar inside (Morin-Crini et al. 2021), cyclodextrins can also be covalently attached in different ways to generate more complex structures (Řezanka 2019). Materials containing more than two covalently linked cyclodextrin units are known as cyclodextrin polymers, and their uses in the field of remediation technologies have been widely explored (Landy et al. 2012). In the case of drug delivery, the most frequently investigated subject among the biomedical applications, the complexation capabilities of cyclodextrins and the controlled release rate of the guest drugs can be modulated with the aid of the additional functionality of a polymeric macrostructure. In other cases, the covalent attachment of cyclodextrin moieties to a pre-existing structure is intended to immobilize them, as in the case of medical devices or packaging applications.

This review covers, from a historical point of view, the applications both in food chemistry and pharmaceutics and biomedicine of cyclodextrin polymers (see Fig. 1). In contrast to the enormous amount of studies on the uses of the parent cyclodextrins in these two sectors, cyclodextrin polymer references are not as abundant and most of the examples found in the literature correspond to the last 10–15 years.

Fig. 1.

Fig. 1

Open in a new tab

Uses of cyclodextrin polymers in the food and pharmaceutical sectors

We can define cyclodextrin polymers as those materials or molecules containing more than two covalently linked cyclodextrin units. Thus, we will not cover in the following sections of this review either the functionalization of non-polymeric supports, known as cyclodextrin nanocomposites, or the amphiphilic cyclodextrins and star polymers with a cyclodextrin core, or the cyclodextrins threaded onto polymer chains, known as polyrotaxanes.

The first references dealing with the potential use of cyclodextrin-containing covalent structures as macromolecular carriers, date back to the 1980s. Since then, they have been incorporated into many constructions, such as hydrogels, nanosponges, dendrimers, interpenetrating networks, molecular imprinted polymers or electrospinned fibres. In addition, some of these systems have proved to be responsive to stimuli, leading to the design of smart multifunctional biomaterials that can be triggered by different factors. This article is an abridged and updated version of the chapter published by Petitjean et al. (2020) in the series Environmental Chemistry for a Sustainable World.

Cyclodextrin polymers

Historical perspective of cyclodextrin polymers

The pioneering work of Solms and Egli in 1965 can be considered as the first landmark in the field of cyclodextrin polymers (Solms and Egli 1965). Also in those early years, Wiedenhof et al. (1969) improved the properties of the irregular crosslinked cyclodextrin particles and produced bead microparticles that, for instance, were suitable to be used in chromatographic columns.

Polyurethane cyclodextrin networks were prepared using diisocyanates by Buckler et al. (1969). Acid dihalides and many other potentially useful space arms were also considered in the same patent and various possible applications of those “anchored” cyclodextrins were explored.

A few years after that, in the mid-1970s, the first cyclodextrin monomers were produced and polymerized by Furue et al. (1975). This acrylic polymer exhibited a greater catalytic effect in the hydrolysis of p-nitrophenyl esters due to the “cooperative effect” between two neighbouring cyclodextrin moieties on a polymeric chain (Harada et al. 1977) (Fig. 2).

Fig. 2.

Fig. 2

Open in a new tab

Cyclodextrin-containing macromolecular systems: a crosslinked cyclodextrin polymers (more than three units); b linear polymers, either grafted-cyclodextrin polymers or monomeric cyclodextrin (co)polymers; c amphiphilic and star-like unimeric cyclodextrins; d (pseudo)polyrotaxanes; e nanocomposites and immobilized cyclodextrins. Only the first two types of structures are covered in this review

The next type of cyclodextrin polymers in our classification corresponds to the attachment of cyclodextrin moieties to previously existing macromolecular materials. In this case, Szejtli, Fenyvesi et al. attached cyclodextrin units to polyvinyl alcohol using epichlorohydrin and epoxy ethers in the late 1970s (Szetjli et al. 1979). Hirayama et al. (1984) used epichlorohydrin to prepare a β-cyclodextrin/starch composite gel. In the 1990s, Pöpping and Deratani (1992) reported the production of monochlorinated cyclodextrins and, later on, other derivatives containing heterocycles were synthesized (Reuscher et al. 1998). Earlier, in 1981, Tanaka et al. had immobilized derivatives of α- and β-cyclodextrin on polyurethane and also onto a polyacrylamide support after activating it with succinyl hydrazide (Tanaka et al. 1981, 1982) with the aim of obtaining stationary phases for the separation of benzene derivatives. About twenty years ago, Crini et al. used cyclodextrin tosyl derivatives to produce macroporous polyamines (1998a) or to modify polyethyleneimines in order to coat silica beads (Crini et al. 1995). Cyclodextrin side chain polyesters were also obtained in those years (Weickenmeier and Wenz 1996). Wenz et al. also reported the synthesis of thickeners based on the specific interaction between cyclodextrin polymers and guest polymers (Weickenmeier and Wenz 1996).

A comprehensive collection of the first polymers can be found in the review of cyclodextrin-containing adsorbents by Crini and Morcellet (2002). In the last two decades, more complex cyclodextrin polymer structures have been produced, namely interpenetrated networks, molecular imprinted polymers, dendrimers, nanogels, polymer assemblies, and nanocomposites. The especial cases of the feasible uses of these materials in these two sectors will be the goal of the last section of this review.

Covalent and supramolecular architectures

Cyclodextrins crosslinked in covalent networks

Cyclodextrin crosslinked with epichlorohydrin polymers, the most abundant in the literature, were also the first type known, synthesized by Solms and Egli (1965). The reaction of saccharides such as glucose with epichlorohydrin is well known (Dumitriu 1996), and the primary product of the reaction of β-cyclodextrin with epichlorohydrin in alkaline media is a heterogeneous mixture of several ethers, of low molecular weight and viscosity, soluble in water. In this reaction, the self-polymerisation of epichlorohydrin, which is favoured at high temperatures, can also occur (Renard et al. 1997).

The bulk synthesis procedure of Solms and Egli (1965) produced irregular polymer particles. A few years after that, Wiedenhof et al. (1969) proposed a two-phase emulsion polymerisation with controlled stirring, in which the cyclodextrin dissolved in water is dispersed in a non-polar organic solvent containing a non-ionic surfactant and the crosslinker in order to produce uniform microspheres, or beads, with better physicochemical properties. As potential drug delivery devices, cyclodextrin–epichlorohydrin hydrogels made with a controlled geometry are useful to obtain kinetic parameters (Machín et al. 2012).

Among the most frequently used non-epoxide crosslinkers are diisocyanates, first introduced by Buckler et al. (1969), as mentioned above. Dihalogenated acid dihalides or dihalogenated dicarboxylic acids of different sizes have also been used as space arms (Buckler et al. 1969; Zemel and Koch 1990), besides other agents such as dihalogenated alkenes or, later on, maleic anhydride (Girek et al. 2000). Shono et al. prepared insoluble porous polymers with a high cyclodextrin content, polymerising α- and β-cyclodextrin with diisocyanates as crosslinking agents in pyridine or dimethylformamide, and studied their capability to absorb aromatic derivatives (Mizobuchi et al. 1980; Tanaka et al. 1981). Certain properties and applications have been studied thereof: stationary phases in chromatography (Lee et al. 2002); artificial cholesterol receptors (Asanuma et al. 1998); solid phase for the extraction of carcinogenic aromatic compounds (Bhaskar et al. 2004). Ma’s group, which also used these two diisocyanates, postulated the presence of interconnected nanoporosity in these polymers (Li and Ma 1999; Ma and Li 1999). The use of difunctional crosslinkers with longer spacers can lead to macromolecular networks with increased porosity, more flexible and less compact. In these networks, smaller molecules can increase their diffusion rates and bulkier substances may also become entrapped (Mocanu et al. 2001). The use of non-toxic crosslinkers like the polycarboxylic acids is also feasible. Martel’s group described the synthesis of soluble and insoluble polymers (Martel et al. 2005) and the production of cotton-bound cyclodextrin using these crosslinkers (Martel et al. 2002).

The analysis of cyclodextrin polymers crosslinked with epichlorohydrin is complicated when it comes to infrared or Raman spectroscopic techniques (Crini et al. 2000) because, as mentioned above, both the crosslinked cyclodextrin units and the self-polymerised epichlorohydrin possess hydroxyalkyl and ether groups. Nevertheless, the interpretation of the infrared spectra of starch crosslinked with epichlorohydrin was resolved at the time (Dumoulin et al. 1998; Delval et al. 2004).

While the spectroscopic characterization of cyclodextrin–epichlorohydrin polymers is not easy, that of cyclodextrin polymers crosslinked with diisocyanates seemed to be simpler. Qualitative characterizations by infrared spectroscopy (Li and Ma 1999; Bhaskar et al. 2004) or Raman (Lee et al. 2002) were attempted, and the successful quantitative analysis was achieved thanks to the intense carbonyl band of the crosslinker (García-Zubiri 2005). Thermal and thermogravimetric analysis were also used in most of those studies, as well as NMR spectroscopy (Asanuma et al. 1998; Lee et al. 2002). For polymers with other crosslinkers, such as maleic anhydride, there were also some NMR results of interest (Girek et al. 2000).

As for the cyclodextrin content of the polymer, the most common procedures used already in the 1990s were the colorimetric methods using chlorotetrazolium blue (Crini et al. 1995; 1998b; Janus et al. 1999) or iodometry (Renard et al. 1997) and phenolphthalein (Mäkelä et al. 1987). For soluble cyclodextrin polymers, proton nuclear magnetic resonance spectroscopy could be used (Renard et al. 1997), and for the insoluble resins 1H or 13C solid-state NMR were employed (Crini et al. 1998b; 2000).

Another technique used to determine the cyclodextrin content in the polymers is CHN elemental analysis (Lee et al. 2002). Nevertheless, it must be used with great care in the case of cyclodextrin–epichlorohydrin polymers due to the similar elemental composition of both constituents (Romo et al. 2006). Important advances in this area have been achieved along the years but the precise characterization of cyclodextrin polymers continues being a challenge as occurs in any other macromolecular materials.

Other novel cyclodextrin polymers

The reticulated cyclodextrins, also known as nanosponges, have evolved into more complex structures in the last 10–20 years (Caldera et al. 2017). Thus, molecular imprinted polymers using cyclodextrin moieties were already produced in the late 1990s (Piletsky et al. 1998). Stimuli responsive polymers based on cyclodextrins were prepared in 1995 using the ubiquitous N-isopropylacrylamide monomer (Nozaki et al. 1995). Interpenetrated networks containing cyclodextrins also appeared at that time (Sreenivasan 1997). Fenyvesi et al. encapsulated several cationic disinfectant agents, in chemically modified (carboxymethylated) nanosponges, based on cyclodextrin linked to polyvinyl alcohol, to be used in the prolonged treatment of wounds (1996).

Nanogels combine the advantages of hydrogels and nanoparticles into a single carrier (Moya-Ortega et al. 2012). Liu et al. prepared cyclodextrin microgels, including one interpenetrated network, by inverse-emulsion polymerisation (2004). About ten years ago, nanoparticles were synthesized by a one-step condensation polymerisation of β-cyclodextrin, choline chloride and epichlorohydrin by Gil et al. (2009). The top-down approach can break bigger networks into the nanoscale size by using ultrasounds (Swaminathan et al. 2010). The water-in-oil emulsion method has been thoroughly employed in the last decade, but their direct synthesis by polymerisation of cyclodextrin monomers is more rare (Moya-Ortega et al. 2012).

Another interesting method of producing nanogels was designed by Gref et al. and consist on supramolecular nanoassemblies between a cyclodextrin–epichlorohydrin polymer and an alkyl-grafted dextran (Gref et al. 2006). Other potential uses of cyclodextrins as ‘smart’ components of polymer nanoparticles were reviewed by Gref and Duchêne (2012). A variety of cyclodextrin-based architectures, e.g. linear, dendrimers, stars, polyrotaxanes, were used in the preparation of polyplexes for gene delivery (Mellet et al. 2011). In 1997, β-cyclodextrin was attached to dendrimer polyethyleneimines (Suh et al. 1997). Two years later, linear cationic alternate copolymers capable of binding DNA with transfection efficiency were prepared by Davis’ group (Gonzalez et al. 1999). Later on, Choi et al. prepared polyplexes grafting cyclodextrin to poly-l-lysine instead of using poly(ethyleneimine) (2005).

Electrospun nanofibres have been used as drug delivery materials due to their high specific area and, obviously, various formulations including cyclodextrins have been tested in the last 5 years (Costoya et al. 2017). Cyclodextrin polymers have been also explored as components of electrospun nanofibres recently (Oliveira et al. 2015). As shown in this short account of the major findings in this field, the evolution of cyclodextrin polymers goes in parallel with the progress in the production of novel macromolecular materials with more complex structures and morphologies, controlled or ‘smart’ behaviours, and specific applications.

Applications in the food and pharmaceutical areas

Cyclodextrin polymers in food science

In the food industry, cyclodextrins have been applied as sorption/release agents and for packaging purposes (Sarkar et al. 2017). They can be used as single cyclodextrins incorporated into fibres (Celebioglu et al. 2018) or films (Plackett et al. 2006). Crosslinked cyclodextrins were firstly proposed for food related applications as early as the 60s with the patent of Bucker et al. (1969) as agents for concentration of flavours or aromas in the food industry.

Cyclodextrin–epichlorohydrin polymers were developed to reduce the bitterness of fruit juices (Shaw et al. 1984), and a selectivity study between bitter molecules and caffeine was tested (Shaw and Buslig 1986), using γ-cyclodextrin polymer as well. It was proved that cyclodextrin polymers do not complex with the latter and studied the importance of the crosslinking agent.

For the same application, β- or γ-cyclodextrin was linked to chitosan through succinyl or maleyl bridges to improve the sorption of bitter compounds (Binello et al. 2004). Thanks to a pilot-plant fluidised-bed procedure, Wagner successes a regeneration of β-cyclodextrin polymer over twenty times without apparent loss of capacity (1988). The debittering of other juices has also been reported later (Szejtli and Szente 2005).

In the last decade, another area of application searched in food science and cosmetics is the retention of fragrance or aroma molecules. Encapsulation of linalool and camphor, composing Lavandula angustifolia essential oil, using crosslinked cyclodextrin–epichlorohydrin polymers was compared to those of the parent and derivative cyclodextrins (Ciobanu et al. 2012). To absorb unwanted molecules present in wine, beads produced using epichlorohydrin (Fliszár-Nyúl et al. 2020) or hexamethylene diisocyanate can be used (Dang et al. 2020).

In 2009, cyclodextrin polymers were used in solid phase extractions to determine additives in food (Li et al. 2009). In parallel, molecular imprinted cyclodextrin polymers were prepared using monomeric cyclodextrin/maleic acid with Congo Red as template and N,N′-methylenebisacrylamide as crosslinker (Liu et al. 2015). Also, a cyclodextrin polymer with a higher specific area has been prepared (Li et al. 2018), grafted onto metallic graphene (Li et al. 2016a), added to ionic liquids (Feng et al. 2015), or imprinted on carbon nanotubes (Liang et al. 2019), in order to remove and/or determine the amount of organic molecules present in food.

Single cyclodextrins are also common for food packaging; they began to be exploited for that purpose at the end of the past century (Szente and Fenyvesi 2018). The first reported use of a cyclodextrin polymer in packaging was to remove an undesirable product in food such as cholesterol (López-De-Dicastillo et al. 2011).

On the other hand, active films are designed to liberate chemicals encapsulated in them using UV stimuli (Tan et al. 2016). To achieve an antibacterial potential, it is also feasible to integrate ZnO nanoparticles into polymer films (Andrade-Del Olmo et al. 2019) or to crosslink a sorbate/cyclodextrin complex, such that with sodium benzoate (Yang et al. 2019). Starting with the applications to extract unwanted molecules from food products several decades ago, the modern uses of cyclodextrin polymers focus also on smart packaging.

Cyclodextrin polymers in drug delivery

The first reviewing of the potential applications of cyclodextrin polymers in the pharmaceutical industry was written by Fenyvesi (1988), and it was mainly based on cyclodextrin crosslinked with epichlorohydrin. A pioneering bioavailability study using a soluble cyclodextrin polymer was reported in the mid-1980s (Uekama et al. 1985). The absorption-promoting effect of the soluble cyclodextrin polymer on the sublingual route was also demonstrated in the case of steroids (Pitha et al. 1986). Karadake et al. (1982) showed that the drug release was retarded and the stability against oxidation and degradation was greatly increased when penicillin complexed with soluble cyclodextrin polymer was microencapsulated.

On the other hand, some applications of the insoluble crosslinked cyclodextrin polymers were also investigated. For instance, its effect on wound healing was tried on tissues of rats (Felméray et al. 1996). In addition, the cyclodextrin–epichlorohydrin sorption capabilities were tested for the removal of phenylalanine from a protein hydrolysate in order to make it digestible for children suffering from phenylketonuria (Specht et al. 1981). Also at that time, the effectiveness of a cyclodextrin polymer as a tablet disintegrant was studied in direct compression systems (Fenyvesi et al. 1984).

Those first attempts to show their capabilities in the sorption and release of aromatic model molecules pointed to the use of cyclodextrin polymers as controlled release agents (Friedman et al. 1989). Specifically, the release of cetylpyridinium chloride, an antimicrobial agent, and iodine, using cyclodextrin polymers, were patented in the late 1980s (Friedman 1988; Szejtli et al. 1988). An earlier example of a cyclodextrin polymer as a macromolecular carrier in the field of antitumor chemotherapy was published also in the mid-1980s (Kaji et al. 1985).

The following decade showed only a few other distinct examples in drug delivery. Thus, drugs complexed in cyclodextrin polymers were entrapped into liposomes (McCormack and Gregoriadis 1994). On the other hand, the need to prepare degradable materials for medical applications, including drug delivery, associating networks using cyclodextrin–epichlorohydrin polymers and degradable copolyesters containing adamantyl groups were tested and were shown to be pH sensitive (Cammas et al. 1999).

Cyclodextrin-based nanosponges have been designed in the last years to increase the dissolution rate, the solubility and stability of drugs, or to prolong the release time, and also applied in semisolid formulations for skin delivery (Ansari et al. 2011; Shende et al. 2013; Conte et al. 2014). Recently, experimental design has been used to formulate tablets using polymeric nanosponges for a combination therapy of three anti-inflammatory drugs (Moin et al. 2020).

As mentioned above, cyclodextrin moieties can be incorporated to pre-existing polymeric materials via grafting reactions. In most of the drug delivery applications, cyclodextrins are attached to polysaccharides (Luzardo-Alvarez et al. 2014), such as chitosan, for which the adsorption and release of ketoprofen, a model drug, was evaluated some time ago (Prabaharan and Mano 2005). Although cyclodextrin adds new drug inclusional properties to the polycationic polymer, a decrease in mucoadhesion of cyclodextrin-chitosan was observed (Venter et al. 2006). More recently, cellulosic substrates were grafted by a cyclodextrin polymer to sustain the release of antibacterial agents (Cusola et al. 2013). Other materials such as poly(hydroxyethylmethacrylate) have also been grafted with β-cyclodextrin for its application in soft contact lenses conservation liquids and to sustain drug delivery in the lacrimal fluid (dos Santos et al. 2009). The use of some cyclodextrin polymers for therapeutics delivery was patented in 2013 (Cheng et al. 2013).

In the turn of the century, a new class of polymers for the delivery of macromolecular therapeutics arose (Gonzalez et al. 1999). Thus, low molecular weight polyethylenimine crosslinked by cyclodextrins demonstrated its lower cytotoxicity and higher transfection efficiency for the delivery of plasmid DNA compared with those of polyethylenimine (Huang et al. 2006). Another significant achievement has been, for instance, the use of a specific functional group such as folic acid grafted to polyethyleneimine-cyclodextrin carriers, to target the tumour cells (Yao et al. 2009). Intranasal mRNA vaccination with the aid of a cationic cyclodextrin-polyethyleneimine conjugate, capable of overcoming the nasal epithelial barrier, has also been recently proposed (Li et al. 2016b).

Drug release behaviour can be modulated with the aid of stimuli responsive polymers and the design of interpenetrated networks (interpenetrated network) permits to combine the temperature responsiveness of poly(N-isopropylamide) gels with the inclusional capabilities of cyclodextrin networks (Zhang et al. 2005). Another semi-interpenetrated network was prepared by the radical polymerisation and crosslinking of N-isopropylacrylamide in the presence of β-cyclodextrin-grafted polyethylenimine (Zhang et al. 2008). Interpenetrated networks can also be used to develop new selective and synergistic sorption capacities for specific purposes such as a combined drug release (Fujiyoshi et al. 2019).

A remarkable pH-responsive behaviour can be achieved using acrylic acid containing polymers (Siemoneit et al. 2006). Other examples have been reported in the recent literature: highly pH-dependent swelling in graft cyclodextrin/acrylic acid copolymers for the delivery of ketoprofen (Wang et al. 2009), or mucoadhesive hydrogels by the crosslinking of poly(acrylic acid) with cyclodextrins for the controlled release of diflunisal and fluconazole (Kutyła et al. 2013). A biocompatible system based on guar gum, poly(acrylic acid) and β-cyclodextrin using a non-toxic crosslinker, tetraethyl orthosilicate, for intestinal delivery of dexamethasone, has also been reported (Das and Subuddhi 2015). A combination of cocktail chemotherapy, photothermal therapy and inhibition of angiogenesis was investigated using an injectable nanocarrier developed by functionalization of carbon nanotubes with a pH a thermoresponsive cyclodextrin polymer (Das et al. 2020).

In the last decade, triple-response (pH, temperature, and glucose) semi-interpenetrated hydrogels were prepared by polymerisation in the presence of the magnetite (Fe3O4) nanoparticles, a cyclodextrin/epichlorohydrin polymer and a crosslinker (Huang et al. 2012). More recently, a carboxymethyl-β-cyclodextrin polymer was grafted on the surface of chitosan-coated magnetite nanoparticles by an emulsion chemical crosslinking method (Ding et al. 2015).

Finally, cyclodextrin polymers have also recently found applications in the field of regenerative medicine (Alvarez-Lorenzo et al. 2017). Vascular polyester and polyamide prostheses can be coated with grafted cyclodextrins that can be loaded with an antibiotic in order to reduce the risk of post-operative infections (Blanchemain et al. 2005). Polyvinylidene difluoride membranes can also be grafted with cyclodextrins to improve the capture and subsequent release of antiseptic agents (Tabary et al. 2007). Polyamide inguinal meshes (El Ghoul et al. 2008) or polypropylene abdominal wall implants for the prolonged delivery of ciprofloxacin (Laurent et al. 2011) have been prepared using citric acid as a crosslinker. Hydroxyapatite used in bone implants can also be functionalized with a cyclodextrin polymer for loading antibiotics (Hoang Thi et al. 2010; Taha et al. 2014). Recently, injectable hydrogels of polyelectrolyte complexes between chitosan and cyclodextrin polymers have been rheologically tested (Palomino-Durand et al. 2019).

As in the case of ‘monomeric’ both natural and derivative cyclodextrins, an increasing number of publications can be found in the most recent literature concerning cyclodextrin polymers, e.g. about 80 papers and reviews in 2020. As Table 1 shows, many reviews have been published in the last six years, and the interested reader is referred to them to acquire a better idea of the goals this field of research is heading and the paths, or approaches, taken. In addition, some other recent reviews also include a section on cyclodextrin-based systems (Larrañeta et al. 2018; Levack et al. 2018; Solanki et al. 2018; Gim et al. 2019). Cyclodextrins have also been recently used to design treatments against the coronavirus disease 2019 (COVID-19) (Carrouel et al. 2020; Ergoren et al. 2020; Sofiane et al. 2020; Szente et al. 2021).

Table 1.

Recent reviews (2015–2021) on the applications of cyclodextrins and cyclodextrin polymers in pharmacy and biomedicine

Authors and year Review title
Simões et al. (2015) Supramolecular cyclodextrin-based drug nanocarriers
Osmani et al. (2015) Cyclodextrin-based nanosponges: Impending carters in drug delivery and nanotherapeutics
Wei and Yu (2015) Cyclodextrin-functionalized polymers as drug carriers for cancer therapy
Gidwani and Vyas (2015) A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs
Gonzalez-Gaitano et al. (2016) Drug carrier systems based on cyclodextrin supramolecular assemblies and polymers: present and perspectives
Mejia-Ariza et al. (2017) Cyclodextrin-based supramolecular nanoparticles for biomedical applications
Peng et al. (2017) Polymeric nanocarriers based on cyclodextrins for drug delivery: host–guest interaction as stimuli responsive linker
Adeoye and Cabral-Marques (2017) Cyclodextrin nanosystems in oral drug delivery: A mini review
Alvarez-Lorenzo et al. (2017) Cyclodextrins as versatile building blocks for regenerative medicine
Fenyvesi et al. (2019) Applications of steroid drugs entrapped in cyclodextrins
Topuz and Uyar (2019) Electrospinning of cyclodextrin functional nanofibres for drug delivery applications
Yao et al. (2019) Cyclodextrin-based polymer materials: From controlled synthesis to applications
Zhang et al. (2019) Cyclodextrin-based delivery systems for cancer treatment
Ciesielska et al. (2020) Biomedical application of cyclodextrin polymers crosslinked via dianhydrides of carboxylic acids
Haley et al. (2020) Cyclodextrins in drug delivery: applications in gene and combination therapy
Qie et al. (2020) Advances in cyclodextrin polymers and their applications in biomedicine
Seidi et al. (2020) Polycyclodextrins: synthesis, functionalization, and applications
Tian et al. (2020a) Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: a review
Tian et al. (2020b) Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems
Wankar et al. (2020) Recent advances in host–guest self‐assembled cyclodextrin carriers: implications for responsive drug delivery and biomedical engineering
Sofiane et al. (2020) The use of cyclodextrin or its complexes as a potential treatment against the 2019 novel coronavirus: a mini-review
Open in a new tab

Conclusion

Immobilized cyclodextrins were first used in the food industry to improve taste, extract some nutrients or flavours, or, more recently, as constituents of the smart packaging of comestible products. The capabilities of the parent and modified cyclodextrins as carriers of substances of low solubility, such as most drugs, were soon exploited for pharmaceutical applications as well. Although the research involving these polymers in the food sector is comparatively scarce, the potential uses in the pharmaceutical and medical sector have been thoroughly investigated, especially in the last decade. A vast amount of papers are currently being published in order to explore the applicability of these interesting materials.

Acknowledgements

The authors wish to thank University of Navarra (PIUNA 2018-15) for the financial support and MP gratefully acknowledges Asociación de Amigos (Universidad de Navarra) for his grant.

Abbreviations

DNA

Deoxyribonucleic acid

NMR

Nuclear magnetic resonance

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Max Petitjean, Email: mpetitjean@alumni.unav.es.

Iñigo X. García-Zubiri, Email: inigo.garcia@magnesitasnavarras.es

José Ramón Isasi, Email: jrisasi@unav.es.

References

  1. Adeoye O, Cabral-Marques H. Cyclodextrin nanosystems in oral drug delivery: a mini review. Int J Pharm. 2017;531:521–531. doi: 10.1016/j.ijpharm.2017.04.050. [DOI] [PubMed] [Google Scholar]
  2. Alvarez-Lorenzo C, García-González CA, Concheiro A. Cyclodextrins as versatile building blocks for regenerative medicine. J Control Release. 2017;268:269–281. doi: 10.1016/j.jconrel.2017.10.038. [DOI] [PubMed] [Google Scholar]
  3. Andrade-Del Olmo J, Pérez-Álvarez L, Hernáez E, Ruiz-Rubio L, Vilas-Vilela JL. Antibacterial multilayer of chitosan and (2-carboxyethyl)- β-cyclodextrin onto polylactic acid (poly-l-lactic acid) Food Hydrocoll. 2019;88:228–323. doi: 10.1016/j.foodhyd.2018.10.014. [DOI] [Google Scholar]
  4. Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech. 2011;12:279–286. doi: 10.1208/s12249-011-9584-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Asanuma H, Kakazu M, Shibata M, Hishiya T, Komiyama M. Synthesis of molecularly imprinted polymer of β-cyclodextrin for the efficient recognition of cholesterol. Supramol Sci. 1998;5:417–421. doi: 10.1016/S0968-5677(98)00042-X. [DOI] [Google Scholar]
  6. Bhaskar M, Aruna P, Jeevan RJG, Radhakrishnan G. β-Cyclodextrin-polyurethane polymer as solid phase extraction material for the analysis of carcinogenic aromatic amines. Anal Chim Acta. 2004;509:39–45. doi: 10.1016/j.aca.2003.12.015. [DOI] [Google Scholar]
  7. Binello A, Cravotto G, Nano GM, Spagliardi P. Synthesis of chitosan-cyclodextrin adducts and evaluation of their bitter-masking properties. Flavour Fragr J. 2004;19:394–400. doi: 10.1002/ffj.1434. [DOI] [Google Scholar]
  8. Blanchemain N, Haulon S, Martel B, Traisnel M, Morcellet M, Hildebrand HF. Vascular PET prostheses surface modification with cyclodextrin coating: development of a new drug delivery system. Eur J Vasc Endovasc Surg. 2005;29:628–632. doi: 10.1016/j.ejvs.2005.02.020. [DOI] [PubMed] [Google Scholar]
  9. Buckler SA, Martel RF, Moshy RJ (1969) Schardinger dextrins. United States Pat. Off. 3472835
  10. Caldera F, Tannous M, Cavalli R, Zanetti M, Trotta F. Evolution of cyclodextrin nanosponges. Int J Pharm. 2017;531:470–479. doi: 10.1016/j.ijpharm.2017.06.072. [DOI] [PubMed] [Google Scholar]
  11. Cammas S, Béar M-M, Moine L, Escalup R, Ponchel G, Kataoka K, Guérin P. Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices. Int J Biol Macromol. 1999;25:273–282. doi: 10.1016/S0141-8130(99)00042-2. [DOI] [PubMed] [Google Scholar]
  12. Carrouel F, Pia Conte M, Fisher J, Souza Gonçalves L, Dussart C, Carlos Llodra J, Bourgeois D. COVID-19: a recommendation to examine the effect of mouthrinses with β-cyclodextrin combined with citrox in preventing infection and progression. J Clin Med. 2020;9(4):1126. doi: 10.3390/jcm9041126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Celebioglu A, Yildiz ZI, Uyar T. Fabrication of electrospun eugenol/cyclodextrin inclusion complex nanofibrous webs for enhanced antioxidant property, water solubility, and high temperature stability. J Agric Food Chem. 2018;66:457–466. doi: 10.1021/acs.jafc.7b04312. [DOI] [PubMed] [Google Scholar]
  14. Cheng J, Davis ME, Khin KT (2013) Cyclodextrin-based polymers for therapeutic delivery. United States Pat. Off. 8389499
  15. Choi HS, Yamashita A, Ooya T, Yui N, Akita H, Kogure K, Ito R, Harashima H. Sunflower-shaped cyclodextrin-conjugated poly(ε-lysine) polyplex as a controlled intracellular trafficking device. ChemBioChem. 2005;6:1986–1990. doi: 10.1002/cbic.200500242. [DOI] [PubMed] [Google Scholar]
  16. Ciesielska A, Ciesielski W, Girek B, Girek T, Koziel K, Kulawik D, Lagiewka J. Biomedical application of cyclodextrin polymers cross-linked via dianhydrides of carboxylic acids. Appl Sci. 2020;10:8463. doi: 10.3390/app10238463. [DOI] [Google Scholar]
  17. Ciobanu A, Mallard I, Landy D, Brabie G, Nistor D, Fourmentin S. Inclusion interactions of cyclodextrins and crosslinked cyclodextrin polymers with linalool and camphor in Lavandula angustifolia essential oil. Carbohydr Polym. 2012;87:1963–1970. doi: 10.1016/j.carbpol.2011.10.005. [DOI] [Google Scholar]
  18. Conte C, Caldera F, Catanzano O, D’Angelo I, Ungaro F, Miro A, Pellosi DS, Trotta F, Quaglia F. β-cyclodextrin nanosponges as multifunctional ingredient in water-containing semisolid formulations for skin delivery. J Pharm Sci. 2014;103:3941–3949. doi: 10.1002/jps.24203. [DOI] [PubMed] [Google Scholar]
  19. Costoya A, Concheiro A, Alvarez-Lorenzo C. Electrospun fibers of cyclodextrins and poly(cyclodextrins) Molecules. 2017 doi: 10.3390/molecules22020230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Crini G, Morcellet M. Synthesis and applications of adsorbents containing cyclodextrins. J Sep Sci. 2002;25:789–813. doi: 10.1002/1615-9314(20020901)25:13<789::AID-JSSC789>3.0.CO;2-J. [DOI] [Google Scholar]
  21. Crini G, Lekchiri Y, Morcellet M. Separation of structural isomers using cyclodextrin-polymers coated on silica beads. Chromatographia. 1995;40:296–302. doi: 10.1007/BF02290360. [DOI] [Google Scholar]
  22. Crini G, Janus L, Morcellet M, Torri G, Naggi A, Bertini S, Vecchi C. Macroporous polyamines containing cyclodextrin: synthesis, characterization, and sorption properties. J Appl Polym Sci. 1998;69:1419–1427. doi: 10.1002/(SICI)1097-4628(19980815)69:7<1419::AID-APP17>3.0.CO;2-O. [DOI] [Google Scholar]
  23. Crini G, Cosentino C, Bertini S, Naggi A, Torri G, Vecchi C, Janus L, Morcellet M. Solid state NMR spectroscopy study of molecular motion in cyclomaltoheptaose (β-cyclodextrin) crosslinked with epichlorohydrin. Carbohydr Res. 1998;308:37–45. doi: 10.1016/S0008-6215(98)00077-9. [DOI] [PubMed] [Google Scholar]
  24. Crini G, Bourdonneau M, Martel B, Piotto M, Morcellet M, Richert T, Vebrel J, Torri G, Morin N. Solid-state NMR characterization of cyclomaltoheptaose (β-cyclodextrin) polymers using high-resolution magic angle spinning with gradients. J Appl Polym Sci. 2000;75:1288–1295. doi: 10.1002/(SICI)1097-4628(20000307)75:10<1288::AID-APP10>3.0.CO;2-J. [DOI] [Google Scholar]
  25. Cusola O, Tabary N, Belgacem MN, Bras J. Cyclodextrin functionalization of several cellulosic substrates for prolonged release of antibacterial agents. J Appl Polym Sci. 2013;129:604–613. doi: 10.1002/app.38748. [DOI] [Google Scholar]
  26. Dang C, Jiranek V, Taylor DK, Wilkinson KL. Removal of volatile phenols from wine using crosslinked cyclodextrin polymers. Molecules. 2020;25(4):1–14. doi: 10.3390/molecules25040910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Das S, Subuddhi U. pH-Responsive guar gum hydrogels for controlled delivery of dexamethasone to the intestine. Int J Biol Macromol. 2015;79:856–863. doi: 10.1016/j.ijbiomac.2015.06.008. [DOI] [PubMed] [Google Scholar]
  28. Das M, Nariya P, Joshi A, Vohra A, Devkar R, Seshadri S, Thakore S. Carbon nanotube embedded cyclodextrin polymer derived injectable nanocarrier: a multiple faceted platform for stimulation of multi-drug resistance reversal. Carbohydr Polym. 2020;247:116751. doi: 10.1016/j.carbpol.2020.116751. [DOI] [PubMed] [Google Scholar]
  29. Delval F, Crini G, Bertini S, Morin-Crini N, Badot PM, Vebrel J, Torri G. Characterization of crosslinked starch materials with spectroscopic techniques. J Appl Polym Sci. 2004;93:2650–2663. doi: 10.1002/app.20851. [DOI] [Google Scholar]
  30. Ding Y, Shen SZ, Sun H, Sun K, Liu F, Qi Y, Yan J. Design and construction of polymerised-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater Sci Eng C Mater Biol Appl. 2015;48:487–498. doi: 10.1016/j.msec.2014.12.036. [DOI] [PubMed] [Google Scholar]
  31. dos Santos J-FR, Alvarez-Lorenzo C, Silva M, Balsa L, Couceiro J, Torres-Labandeira J-J, Concheiro A. Soft contact lenses functionalized with pendant cyclodextrins for controlled drug delivery. Biomaterials. 2009;30:1348–1355. doi: 10.1016/j.biomaterials.2008.11.016. [DOI] [PubMed] [Google Scholar]
  32. Dumitriu S. Polysaccharides in medicinal applications. New York: Routledge; 1996. [Google Scholar]
  33. Dumoulin Y, Alex S, Szabo P, Cartilier L, Mateescu MA. Cross-linked amylose as matrix for drug controlled release. X-ray and FT-IR structural analysis. Carbohydr Polym. 1998;37:361–370. doi: 10.1016/S0144-8617(98)00058-7. [DOI] [Google Scholar]
  34. El Ghoul Y, Blanchemain N, Laurent T, Campagne C, El Achari A, Roudesli S, Morcellet M, Martel B, Hildebrand HF. Chemical, biological and microbiological evaluation of cyclodextrin finished polyamide inguinal meshes. Acta Biomater. 2008;4:1392–1400. doi: 10.1016/j.actbio.2008.02.019. [DOI] [PubMed] [Google Scholar]
  35. Ergoren MC, Paolacci S, Manara E, Dautaj A, Dhuli K, Anpilogov K, Camilleri G, Suer HK, Sayan M, Tuncel G, Sultanoglu N, Farronato M, Tartaglia GM, Dundar M, Farronato G, Gunsel IS, Bertelli M, Sanlidag T. A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission. Acta bio-medica : Atenei Parmensis. 2020;91(13-S):e2020022. doi: 10.23750/abm.v91i13-S.10817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Felméray I, Fenyvesi É, Neumark T, Takács J, Gerlóczy A, Szejtli J (1996) Effect of cyclodextrin bead polymer on wound healing. In: Proceedings of eighth international symposium cyclodextrins, pp 491–494. 10.1007/978-94-011-5448-2_108
  37. Feng G, Ping W, Qin XX, Liu J, Zhu X. Ionic-liquid-loaded β-cyclodextrin-cross-linked polymer solid-phase extraction for the separation/analysis of linuron in fruit and vegetable samples. Food Anal Methods. 2015;8:2315–2320. doi: 10.1007/s12161-015-0118-6. [DOI] [Google Scholar]
  38. Fenyvesi E. Cyclodextrin polymers in the pharmaceutical industry. J Incl Phenom. 1988;6:537–545. doi: 10.1007/BF00660751. [DOI] [Google Scholar]
  39. Fenyvesi E, Shirakura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull. 1984;32:665–669. doi: 10.1248/cpb.32.665. [DOI] [PubMed] [Google Scholar]
  40. Fenyvesi É, Ujházy A, Szejtli J, Pütter S, Gan TG. Controlled release of drugs from cyclodextrin polymers substituted with ionic groups. J Incl Phenom Mol Recognit Chem. 1996;25:185–189. doi: 10.1007/BF01041566. [DOI] [Google Scholar]
  41. Fenyvesi É, Puskás I, Szente L. Applications of steroid drugs entrapped in cyclodextrins. Environ Chem Lett. 2019;17:375–391. doi: 10.1007/s10311-018-0807-7. [DOI] [Google Scholar]
  42. Fliszár-Nyúl E, Szabó Á, Szente L, Poór M. Extraction of mycotoxin alternariol from red wine and from tomato juice with beta-cyclodextrin bead polymer. J Mol Liq. 2020;319:114180. doi: 10.1016/j.molliq.2020.114180. [DOI] [Google Scholar]
  43. Friedman RB (1988) Controlled release agent for cetylpyridinium chloride. United States Pat. Off. 4774329
  44. Friedman RB, Hedges AR, Black FL, Gottneid DJ. Complexation of aromatic compounds with, and their release from, cyclomaltoheptaose-containing polymers, hydroxyethylcyclomaltoheptaose, and cyclomaltoheptaose. Carbohydr Res. 1989;192:283–289. doi: 10.1016/0008-6215(89)85186-9. [DOI] [Google Scholar]
  45. Fujiyoshi T, Carrez O, Imizcoz M, Zornoza A, Isasi JR. Interpenetrated polymer networks of poly(β-cyclodextrin)and polyvinylpyrrolidone with synergistic and selective sorption capacities. Carbohydr Polym. 2019;219:105–112. doi: 10.1016/j.carbpol.2019.05.027. [DOI] [PubMed] [Google Scholar]
  46. Furue M, Harada A, Nozakura S. Preparation of cyclodextrin-containing polymers and their catalysis in ester-hydrolysis. J Polym Sci Polym Lett Ed. 1975;13:357–360. doi: 10.1002/pol.1975.130130608. [DOI] [Google Scholar]
  47. García-Zubiri ÍX (2005) Sorption of naphthalenes in beta-ciclodextrin polymers. Ph.D. thesis, University of Navarra
  48. Gidwani B, Vyas A. A comprehensive review on cyclodextrin based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed Res Int. 2015;2015:198268. doi: 10.1155/2015/198268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Gil ES, Li J, Xiao H, Lowe TL. Quaternary ammonium β-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier. Biomacromolecules. 2009;10:505–516. doi: 10.1021/bm801026k. [DOI] [PubMed] [Google Scholar]
  50. Gim S, Zhu Y, Seeberger PH, Delbianco M. Carbohydrate-based nanomaterials for biomedical applications. Wiley Interdiscip Rev Nanomed Nanonbiotechnol. 2019;11(5):e1558. doi: 10.1002/wnan.1558. [DOI] [PubMed] [Google Scholar]
  51. Girek T, Shin DH, Lim ST. Polymerisation of β-cyclodextrin with maleic anhydride and structural characterization of the polymers. Carbohydr Polym. 2000;42:59–63. doi: 10.1016/S0144-8617(99)00138-1. [DOI] [Google Scholar]
  52. Gonzalez H, Hwang SJ, Davis ME. New class of polymers for the delivery of macromolecular therapeutics. Bioconjugate Chem. 1999;10:1068–1074. doi: 10.1021/bc990072j. [DOI] [PubMed] [Google Scholar]
  53. Gonzalez-Gaitano G, Isasi J, Velaz I, Zornoza A. Drug carrier systems based on cyclodextrin supramolecular assemblies and polymers: present and perspectives. Curr Pharm Des. 2016;23:411–432. doi: 10.2174/1381612823666161118145309. [DOI] [PubMed] [Google Scholar]
  54. Gref R, Duchêne D. Cyclodextrins as “smart” components of polymer nanoparticles. J Drug Deliv Sci Technol. 2012;22:223–233. doi: 10.1016/S1773-2247(12)50033-X. [DOI] [Google Scholar]
  55. Gref R, Amiel C, Molinard K, Daoud-Mahammed S, Sébille B, Gillet B, Beloeil J-C, Ringard C, Rosilio V, Poupaert J, Couvreur P. New self-assembled nanogels based on host-guest interactions: characterization and drug loading. J Control Release. 2006;111:316–324. doi: 10.1016/j.jconrel.2005.12.025. [DOI] [PubMed] [Google Scholar]
  56. Haley RM, Gottardi R, Langer R, Mitchell MJ. Cyclodextrins in drug delivery: applications in gene and combination therapy. Drug Deliv Transl Res. 2020;10:661–677. doi: 10.1007/s13346-020-00724-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Harada A, Furue M, Nozakura SI. Interaction of cyclodextrin-containing polymers with fluorescent compounds. Macromolecules. 1977;10:676–681. doi: 10.1021/ma60057a036. [DOI] [Google Scholar]
  58. Hirayama C, Kosugi Y, Motozato Y. Studies on inclusion behaviors of β-cyclodextrin-starch composite gel by spin probe method. J Macromol Sci Part A Chem. 1984;21:1487–1492. doi: 10.1080/00222338408055677. [DOI] [Google Scholar]
  59. Hoang Thi TH, Chai F, Leprêtre S, Blanchemain N, Martel B, Siepmann F, Hildebrand HF, Siepmann J, Flament MP. Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel. Int J Pharm. 2010;400:74–85. doi: 10.1016/j.ijpharm.2010.08.035. [DOI] [PubMed] [Google Scholar]
  60. Huang H, Tang G, Wang Q, Li D, Shen F, Zhou J, Yu H. Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-beta-cyclodextrin or (2-hydroxypropyl)-gamma-cyclodextrin. Chem Commun (Camb) 2006;600:2382–2384. doi: 10.1039/b601130f. [DOI] [PubMed] [Google Scholar]
  61. Huang Y, Liu M, Chen J, Gao C, Gong Q. A novel magnetic triple-responsive composite semi-interpenetrated network hydrogels for targeted and controlled drug delivery. Eur Polym J. 2012;48:1734–1744. doi: 10.1016/j.eurpolymj.2012.06.012. [DOI] [Google Scholar]
  62. Janus L, Crini G, El-Rezzi V, Morcellet M, Cambiaghi A, Torri G, Naggi A, Vecchi C. New sorbents containing beta-cyclodextrin. Synthesis, characterization, and sorption properties. React Funct Polym. 1999;42:173–180. doi: 10.1016/S1381-5148(98)00066-2. [DOI] [Google Scholar]
  63. Kaji Y, Uekama K, Yoshikawa H, Takada K, Muranishi S. Selective transfer of 1-hexylcarbamoyl-5-fluorouracil into lymphatics by combination of β-cyclodextrin polymer complexation and absorption promoter in the rat. Int J Pharm. 1985;24:79–89. doi: 10.1016/0378-5173(85)90145-0. [DOI] [Google Scholar]
  64. Karadake K, Morimoto T, Tsuda K (1982) Japan Kokai 57-130914. Japan Kokai 57:130914
  65. Kutyła MJ, Lambert LK, Davies NM, McGeary RP, Shaw PN, Ross BP. Cyclodextrin-crosslinked poly(acrylic acid): synthesis, physicochemical characterization and controlled release of diflunisal and fluconazole from hydrogels. Int J Pharm. 2013;444:175–184. doi: 10.1016/j.ijpharm.2013.01.005. [DOI] [PubMed] [Google Scholar]
  66. Landy D, Mallard I, Ponchel A, Monflier E, Fourmentin S. Remediation technologies using cyclodextrins: an overview. Environ Chem Lett. 2012;10:225–237. doi: 10.1007/s10311-011-0351-1. [DOI] [Google Scholar]
  67. Larrañeta E, Stewart S, Ervine M, Al-Kasasbeh R, Donnelly RF. Hydrogels for hydrophobic drug delivery. Classification, synthesis and applications. J Funct Biomater. 2018 doi: 10.3390/jfb9010013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Laurent T, Kacem I, Blanchemain N, Cazaux F, Neut C, Hildebrand HF, Martel B. Cyclodextrin and maltodextrin finishing of a polypropylene abdominal wall implant for the prolonged delivery of ciprofloxacin. Acta Biomater. 2011;7:3141–3149. doi: 10.1016/j.actbio.2011.04.020. [DOI] [PubMed] [Google Scholar]
  69. Lee KP, Choi SH, Ryu EN, Ryoo JJ, Park JH, Kim Y, Hyun MH. Preparation and characterization of cyclodextrin polymer and its high-performance liquid-chromatography stationary phase. Anal Sci. 2002;18:31–34. doi: 10.2116/analsci.18.31. [DOI] [PubMed] [Google Scholar]
  70. Levack AE, Cyphert EL, Bostrom MP, Hernandez CJ, von Recum HA, Carli AV. Current options and emerging biomaterials for periprosthetic joint infection. Curr Rheumatol Rep. 2018 doi: 10.1007/s11926-018-0742-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Li D, Ma M. Nanosponges: from inclusion chemistry to water purifying technology. ChemTech. 1999;29:31–37. [Google Scholar]
  72. Li R, Jiang ZT, Wang RX. Solid phase extraction combined direct spectrophotometric determination of brilliant blue in food using β-cyclodextrin polymer. Food Anal Methods. 2009;2:264–270. doi: 10.1007/s12161-008-9065-9. [DOI] [Google Scholar]
  73. Li M, Zhao M, Fu Y, Li Y, Gong T, Zhang Z, Sun X. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. J Control Release. 2016;228:9–19. doi: 10.1016/j.jconrel.2016.02.043. [DOI] [PubMed] [Google Scholar]
  74. Li J, Wang X, Duan H, Wang Y, Bu Y, Luo C. Based on magnetic graphene oxide highly sensitive and selective imprinted sensor for determination of sunset yellow. Talanta. 2016;147:169–176. doi: 10.1016/j.talanta.2015.09.056. [DOI] [PubMed] [Google Scholar]
  75. Li Y, Lu P, Cheng J, Wang Q, He C. Simultaneous solid-phase extraction and determination of three bisphenols in water samples and orange juice by a porous β-cyclodextrin polymer. Food Anal Methods. 2018;11:1476–1484. doi: 10.1007/s12161-017-1131-8. [DOI] [Google Scholar]
  76. Liang G, Guo X, Tan X, Mai S, Chen Z, Zhai H. Molecularly imprinted monolithic column based on functionalized β-cyclodextrin and multi-walled carbon nanotubes for selective recognition of benzimidazole residues in citrus samples. Microchem J. 2019;146:1285–1294. doi: 10.1016/j.microc.2019.02.064. [DOI] [Google Scholar]
  77. Liu YY, Fan XD, Kang T, Sun L. A cyclodextrin microgel for controlled release driven by inclusion effects. Macromol Rapid Commun. 2004;25:1912–1916. doi: 10.1002/marc.200400396. [DOI] [Google Scholar]
  78. Liu F, Zhang S, Wang G, Zhao J, Guo Z. A novel bifunctional molecularly imprinted polymer for determination of Congo red in food. RSC Adv. 2015;5:22811–22817. doi: 10.1039/c4ra14719g. [DOI] [Google Scholar]
  79. López-De-Dicastillo C, Jordá M, Catalá R, Gavara R, Hernández-Muñoz P. Development of active polyvinyl alcohol/β-cyclodextrin composites to scavenge undesirable food components. J Agric Food Chem. 2011;59:11026–11033. doi: 10.1021/jf200749f. [DOI] [PubMed] [Google Scholar]
  80. Luzardo-Alvarez A, Sobarzo-Sanchez E, Blanco-Mendez J, Otero-Espinar FJ. Cyclodextrin-based polysaccharidic polymers: an approach for the drug delivery. Curr Top Med Chem. 2014;14:542–551. doi: 10.2174/1568026613666131219125419. [DOI] [PubMed] [Google Scholar]
  81. Ma M, Li DQ. New organic nanoporous polymers and their inclusion complexes. Chem Mater. 1999;11:872–874. doi: 10.1021/cm981090y. [DOI] [Google Scholar]
  82. Machín R, Isasi JR, Vélaz I. β-Cyclodextrin hydrogels as potential drug delivery systems. Carbohydr Polym. 2012;87:2024–2030. doi: 10.1016/j.carbpol.2011.10.024. [DOI] [Google Scholar]
  83. Mäkelä M, Korpela T, Laakso S. Colorimetric determination of β-cyclodextrin: two assay modifications based on molecular complexation of phenolphatalein. J Biochem Biophys Methods. 1987;14:85–92. doi: 10.1016/0165-022X(87)90043-1. [DOI] [PubMed] [Google Scholar]
  84. Martel B, Weltrowski M, Ruffin D, Morcellet M. Polycarboxylic acids as crosslinking agents for grafting cyclodextrins onto cotton and wool fabrics: study of the process parameters. J Appl Polym Sci. 2002;83:1449–1456. doi: 10.1002/app.2306. [DOI] [Google Scholar]
  85. Martel B, Ruffin D, Weltrowski M, Lekchiri Y, Morcellet M. Water-soluble polymers and gels from the polycondensation between cyclodextrins and poly(carboxylic acid)s: a study of the preparation parameters. J Appl Polym Sci. 2005;97:433–442. doi: 10.1002/app.21391. [DOI] [Google Scholar]
  86. McCormack B, Gregoriadis G. Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int J Pharm. 1994;112:249–258. doi: 10.1016/0378-5173(94)90361-1. [DOI] [Google Scholar]
  87. Mejia-Ariza R, Graña-Suárez L, Verboom W, Huskens J. Cyclodextrin-based supramolecular nanoparticles for biomedical applications. J Mater Chem B. 2017;5:36–52. doi: 10.1039/c6tb02776h. [DOI] [PubMed] [Google Scholar]
  88. Mellet CO, Fernández JMG, Benito JM. Cyclodextrin-based gene delivery systems. Chem Soc Rev. 2011;40:1586–1608. doi: 10.1039/C0CS00019A. [DOI] [PubMed] [Google Scholar]
  89. Mizobuchi Y, Tanaka M, Shono T. Preparation and sorption behaviour of cyclodextrin polyurethane resins. J Chromatogr A. 1980;194:153–161. doi: 10.1016/S0021-9673(00)87291-X. [DOI] [Google Scholar]
  90. Mocanu G, Vizitiu D, Carpov A. Cyclodextrin polymers. J Bioact Compat Polym. 2001;16:315–342. doi: 10.1106/JJUV-8F2K-JGYF-HNGF. [DOI] [Google Scholar]
  91. Moin A, Famna Roohi NK, Rizvi SMD, Ashraf SA, Siddiqui AJ, Patel M, Ahmed SM, Gowda DV, Adnan M. Design and formulation of polymeric nanosponge tablets with enhanced solubility for combination therapy. RSC Adv. 2020;10:34869. doi: 10.1039/d0ra06611g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Morin-Crini N, Fourmentin S, Fenyvesi É, Lichtfouse E, Torri G, Fourmentin M, Crini G. 130 years of cyclodextrin discovery for health, food, agriculture, and the industry: a review. Environ Chem Lett. 2021 doi: 10.1007/s10311-020-01156-w. [DOI] [Google Scholar]
  93. Moya-Ortega MD, Alvarez-Lorenzo C, Concheiro A, Loftsson T. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int J Pharm. 2012;428:152–163. doi: 10.1016/j.ijpharm.2012.02.038. [DOI] [PubMed] [Google Scholar]
  94. Nozaki T, Maeda Y, Ito K, Kitano H. Cyclodextrins modified with polymer chains which are responsive to external stimuli. Macromolecules. 1995;28:522–524. doi: 10.1021/ma00106a016. [DOI] [Google Scholar]
  95. Oliveira MF, Suarez D, Rocha JCB, De Carvalho Teixeira AVN, Cortés ME, De Sousa FB, Sinisterra RD. Electrospun nanofibers of polycyclodextrin/PMAA polymers and their potential application as drug delivery system. Mater Sci Eng C. 2015;54:252–261. doi: 10.1016/j.msec.2015.04.042. [DOI] [PubMed] [Google Scholar]
  96. Osmani RAM, Bhosale RR, Hani U, Vaghela R, Kulkarni PK. Cyclodextrin based nanosponges: impending carters in drug delivery and nanotherapeutics. Curr Drug Ther. 2015;10:3–19. doi: 10.2174/157488551001150825095513. [DOI] [Google Scholar]
  97. Palomino-Durand C, Lopez M, Cazaux F, Martel B, Blanchemain N, Chai F. Influence of the soluble-insoluble ratios of cyclodextrins polymers on the viscoelastic properties of injectable chitosan-based hydrogels for biomedical application. Polymers (Basel) 2019 doi: 10.3390/polym11020214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Peng L, Liu S, Feng A, Yuan J. Polymeric nanocarriers based on cyclodextrins for drug delivery: host-guest interaction as stimuli responsive linker. Mol Pharm. 2017;14:2475–2486. doi: 10.1021/acs.molpharmaceut.7b00160. [DOI] [PubMed] [Google Scholar]
  99. Petitjean M, García-Zubiri I, Isasi JR. Cyclodextrin-based polymers for food and pharmaceutical applications: a historical review. In: Crini G, Fourmentin S, Lichtfouse E, editors. The history of cyclodextrins: environmental chemistry for a sustainable world. Cham: Springer; 2020. [Google Scholar]
  100. Piletsky SA, Andersson HS, Nicholls IA. The rational use of hydrophobic effect-based recognition in molecularly imprinted polymers. J Mol Recognit. 1998;11:94–97. doi: 10.1002/(SICI)1099-1352(199812)11:1/6<94::AID-JMR398>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  101. Pitha J, Harman SM, Michel ME. Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones. J Pharm Sci. 1986;75:165–167. doi: 10.1002/jps.2600750213. [DOI] [PubMed] [Google Scholar]
  102. Plackett DV, Holm VK, Johansen P, Ndoni S, Nielsen PV, Sipilainen-Malm T, Södergård A, Verstichel S. Characterization of l-polylactide and l-polylactide-polycaprolactone co-polymer films for use in cheese-packaging applications. Packag Technol Sci. 2006;19:1–24. doi: 10.1002/pts.704. [DOI] [Google Scholar]
  103. Pöpping B, Deratani A. Synthesis of cyclodextrins with pendant chlorinated groups. Reaction of β-cyclodextrin with epichlorohydrin in acidic medium. Die Makromol Chemie Rapid Commun. 1992;13:237–241. doi: 10.1002/marc.1992.030130409. [DOI] [Google Scholar]
  104. Prabaharan M, Mano JF. Hydroxypropyl chitosan bearing β-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug. Macromol Biosci. 2005;5:965–973. doi: 10.1002/mabi.200500087. [DOI] [PubMed] [Google Scholar]
  105. Qie S, Hao Y, Liu Z, Wang J, Xi J. Advances in cyclodextrin polymers and their applications in biomedicine (in Chinese) Acta Chim Sin. 2020;78:232–244. doi: 10.6023/A20010006. [DOI] [Google Scholar]
  106. Renard E, Deratani A, Volet G, Sebille B. Preparation and characterization of water soluble high molecular weight β-cyclodextrin–epichlorohydrin polymers. Eur Polym J. 1997;33:49–57. doi: 10.1016/S0014-3057(96)00123-1. [DOI] [Google Scholar]
  107. Reuscher H, Hirsenkorn R, Haas W (1998) Cyclodextrin derivatives having at least one nitrogen-containing heterocycle, their preparation and use. United States Pat. US 5728823
  108. Řezanka M. Synthesis of substituted cyclodextrins. Environ Chem Lett. 2019;17:49–63. doi: 10.1007/s10311-018-0779-7. [DOI] [Google Scholar]
  109. Romo A, Peñas FJ, Sevillano X, Isasi JR. Application of factorial experimental design to the study of the suspension polymerisation of β-cyclodextrin and epichlorohydrin. J Appl Polym Sci. 2006;100:3393–3402. doi: 10.1002/app.23778. [DOI] [Google Scholar]
  110. Sarkar P, Choudhary R, Panigrahi S, Syed I, Sivapratha S, Dhumal CV. Nano-inspired systems in food technology and packaging. Environ Chem Lett. 2017;15:607–622. doi: 10.1007/s10311-017-0649-8. [DOI] [Google Scholar]
  111. Seidi F, Jin Y, Xiao H. Polycyclodextrins: synthesis, functionalization, and applications. Carbohydr Polym. 2020;242:116277. doi: 10.1016/j.carbpol.2020.116277. [DOI] [PubMed] [Google Scholar]
  112. Shaw PE, Buslig BS. Selective removal of bitter compounds from grapefruit juice and from aqueous solution with cyclodextrin polymers and with Amberlite XAD-4. J Agric Food Chem. 1986;34:837–840. doi: 10.1021/jf00071a018. [DOI] [Google Scholar]
  113. Shaw PE, Tatum JH, Wilson CW. Improved flavor of navel orange and grapefruit juices by removal of bitter components with β-cyclodextrin polymer. J Agric Food Chem. 1984;32:832–836. doi: 10.1021/jf00124a034. [DOI] [Google Scholar]
  114. Shende P, Deshmukh K, Trotta F, Caldera F. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia. Int J Pharm. 2013;456:95–100. doi: 10.1016/j.ijpharm.2013.08.012. [DOI] [PubMed] [Google Scholar]
  115. Siemoneit U, Schmitt C, Alvarez-Lorenzo C, Luzardo A, Otero-Espinar F, Concheiro A, Blanco-Méndez J. Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability. Int J Pharm. 2006;312:66–74. doi: 10.1016/j.ijpharm.2005.12.046. [DOI] [PubMed] [Google Scholar]
  116. Simões SMN, Rey-Rico A, Concheiro A, Alvarez-Lorenzo C. Supramolecular cyclodextrin-based drug nanocarriers. Chem Commun. 2015;51:6275–6289. doi: 10.1039/c4cc10388b. [DOI] [PubMed] [Google Scholar]
  117. Sofiane F, Lamia T, Mohamed S, Mokrane I-O. The use of cyclodextrin or its complexes as a potential treatment against the 2019 novel coronavirus. A mini-review. Curr Drug Deliv. 2020;18:382. doi: 10.2174/1567201817666200917124241. [DOI] [PubMed] [Google Scholar]
  118. Solanki A, Das M, Thakore S. A review on carbohydrate embedded polyurethanes: an emerging area in the scope of biomedical applications. Carbohydr Polym. 2018;181:1003–1016. doi: 10.1016/j.carbpol.2017.11.049. [DOI] [PubMed] [Google Scholar]
  119. Solms J, Egli RH. Harze mit einschlusshohlraumen von cyclodextrin-struktur. Helv Chim Acta. 1965;48:1225. doi: 10.1002/hlca.19650480603. [DOI] [Google Scholar]
  120. Specht M, Rothe M, Szente L, Szejtli J (1981) Removal of phenylalanine from protein hydrolysates. Ger. Offen. 147615
  121. Sreenivasan K. Absorption characteristics of a novel semi-interpenetrated network membrane based on β-cyclodextrin toward testosterone and progesterone. J Appl Polym Sci. 1997;64:1811–1814. doi: 10.1002/(SICI)1097-4628(19970531)64:9<1811::AID-APP17>3.0.CO;2-#. [DOI] [Google Scholar]
  122. Suh J, Hah SS, Lee SH. Dendrimer poly (ethylenimine)s linked to beta-cyclodextrin. Biorgan Chem. 1997;25:63–75. doi: 10.1006/bioo.1996.1054. [DOI] [Google Scholar]
  123. Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D, Trotta M, Zara GP, Cavalli R. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm. 2010;74:193–201. doi: 10.1016/j.ejpb.2009.11.003. [DOI] [PubMed] [Google Scholar]
  124. Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm. 2005;61:115–125. doi: 10.1016/j.ejpb.2005.05.006. [DOI] [PubMed] [Google Scholar]
  125. Szejtli J, Fenyvesi E, Sarkoezi P, Felmeray I, Zsoldos A (1988) Cyclodextrin polymer/iodine inclusion compounds with controlled release of iodine. Ger. Offen. DE3819498A1
  126. Szente L, Fenyvesi É. Cyclodextrin-enabled polymer composites for packaging. Molecules. 2018;23:1556. doi: 10.3390/molecules23071556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Szente L, Puskás I, Sohajda T, Varga E, Vass P, Kristóf Nagy Z, Farkas A, Várnai B, Béni S, Hazai E. Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: characterization of electrospun- and lyophilized formulations. Carbohydr Polym. 2021;264:118011. doi: 10.1016/j.carbpol.2021.118011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Szetjli J, Fenyvesi E, Zoltan S, Zsadon B, Tudos F (1979) Cyclodextrin-poly(vinyl alcohol) polymers in the form of beads, sheet, fibers or blocks. Hung. Pat. 19626; U. S. Pat. 4274985
  129. Tabary N, Lepretre S, Boschin F, Blanchemain N, Neut C, Delcourt-Debruyne E, Martel B, Morcellet M, Hildebrand HF. Functionalization of PVDF membranes with carbohydrate derivates for the controlled delivery of chlorhexidin. Biomol Eng. 2007;24:472–476. doi: 10.1016/j.bioeng.2007.07.007. [DOI] [PubMed] [Google Scholar]
  130. Taha M, Chai F, Blanchemain N, Neut C, Goube M, Maton M, Martel B, Hildebrand HF. Evaluation of sorption capacity of antibiotics and antibacterial properties of a cyclodextrin-polymer functionalized hydroxyapatite-coated titanium hip prosthesis. Int J Pharm. 2014;477:380–389. doi: 10.1016/j.ijpharm.2014.10.026. [DOI] [PubMed] [Google Scholar]
  131. Tan S, Cui J, Fu Q, Nam E, Ladewig K, Ren JM, Wong EHH, Caruso F, Blencowe A, Qiao GG. Photocontrolled cargo release from dual cross-linked polymer particles. ACS Appl Mater Interfaces. 2016;8:6219–6228. doi: 10.1021/acsami.5b11186. [DOI] [PubMed] [Google Scholar]
  132. Tanaka M, Mizobuchi Y, Kuroda T, Shono T. Sorption behaviour of several organic compounds on 6-deoxycyclodextrin polyurethane resins. J Chromatogr A. 1981;219:108–112. doi: 10.1016/S0021-9673(00)80579-8. [DOI] [Google Scholar]
  133. Tanaka M, Kawaguchi Y, Nakae M, Mizobuchi Y, Shono T. Separation of disubstituted benzene isomers on chemically bonded cyclodextrin stationary phases. J Chromatogr. 1982;246:207–214. doi: 10.1016/S0021-9673(00)95860-6. [DOI] [Google Scholar]
  134. Tian B, Liu Y, Jiayue Liu J. Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems. Carbohydr Polym. 2020;242:116401. doi: 10.1016/j.carbpol.2020.116401. [DOI] [PubMed] [Google Scholar]
  135. Tian B, Hua S, Liu J. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: a review. Carbohydr Polym. 2020;232:115805. doi: 10.1016/j.carbpol.2019.115805. [DOI] [PubMed] [Google Scholar]
  136. Topuz F, Uyar T. Electrospinning of cyclodextrin functional nanofibers for drug delivery applications. Pharmaceutics. 2019 doi: 10.3390/pharmaceutics11010006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Uekama K, Otagiri M, Irie T, Seo H, Tsuruoka M. Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble. Int J Pharm. 1985;23:35–42. doi: 10.1016/0378-5173(85)90220-0. [DOI] [PubMed] [Google Scholar]
  138. Venter JP, Kotzé AF, Auzély-Velty R, Rinaudo M. Synthesis and evaluation of the mucoadhesivity of a cyclodextrin-chitosan derivative. Int J Pharm. 2006;313:36–42. doi: 10.1016/j.ijpharm.2006.01.016. [DOI] [PubMed] [Google Scholar]
  139. Wagner CJ, Jr, Wilson CW, III, Shaw PE. Reduction of grapefruit bitter components in a fluidized β-cyclodextrin polymer bed. J Food Sci. 1988;53:516–518. doi: 10.1111/j.1365-2621.1988.tb07745.x. [DOI] [Google Scholar]
  140. Wang Q, Li S, Liu H, Zhang H, Li C. The molecular inclusion function and pH-sensitivity of hydrogel as a novel drug delivery system. J Drug Deliv Sci Technol. 2009;19:145–150. doi: 10.1016/S1773-2247(09)50023-8. [DOI] [Google Scholar]
  141. Wankar J, Kotla NG, Gera S, Rasala S, Pandit A, Rochev YA. Recent advances in host–guest self-assembled cyclodextrin carriers: implications for responsive drug delivery and biomedical engineering. Adv Funct Mater. 2020;30:1909049. doi: 10.1002/adfm.201909049. [DOI] [Google Scholar]
  142. Wei H, Yu CY. Cyclodextrin-functionalized polymers as drug carriers for cancer therapy. Biomater Sci. 2015;3:1050–1060. doi: 10.1039/c4bm00417e. [DOI] [PubMed] [Google Scholar]
  143. Weickenmeier M, Wenz G. Cyclodextrin sidechain polyesters—synthesis and inclusion of adamantan derivatives. Macromol Rapid Commun. 1996;17:731–736. doi: 10.1002/marc.1996.030171008. [DOI] [Google Scholar]
  144. Wiedenhof N, Lammers JNJJ, van Panthaleon Van Eck CL. Properties of cyclodextrins part III. Cyclodextrin–epichlorhydrin resins: preparation and analysis. Starch Stärke. 1969;21:119–123. doi: 10.1002/star.19690210504. [DOI] [Google Scholar]
  145. Yang YC, Mei XW, Hu YJ, Su LY, Bian J, Li MF, Peng F, Sun RC. Fabrication of antimicrobial composite films based on xylan from pulping process for food packaging. Int J Biol Macromol. 2019;134:122–130. doi: 10.1016/j.ijbiomac.2019.05.021. [DOI] [PubMed] [Google Scholar]
  146. Yao H, Ng SS, Tucker WO, Tsang YKT, Man K, Wang X, Chow BKC, Kung HF, Tang GP, Lin MC. The gene transfection efficiency of a folate-poly(ethyleneimine)600-cyclodextrin nanopolymer. Biomaterials. 2009;30:5793–5803. doi: 10.1016/j.biomaterials.2009.06.051. [DOI] [PubMed] [Google Scholar]
  147. Yao X, Huang P, Nie Z. Cyclodextrin-based polymer materials: from controlled synthesis to applications. Prog Polym Sci. 2019;93:1–35. doi: 10.1016/j.progpolymsci.2019.03.004. [DOI] [Google Scholar]
  148. Zemel H, Koch MB (1990) Preparation of crosslinked cyclodextrin resins with enhanced porosity. United States Pat. Off. 4958015
  149. Zhang JT, Huang SW, Gao FZ, Zhuo RX. Novel temperature-sensitive, β-cyclodextrin-incorporated poly(N-isopropylacrylamide) hydrogels for slow release of drug. Colloid Polym Sci. 2005;283:461–464. doi: 10.1007/s00396-004-1224-y. [DOI] [Google Scholar]
  150. Zhang J-T, Xue YN, Gao F-Z, Huang SW, Zhuo RX. Preparation of temperature-sensitive poly(N-isopropylacrylamide)/β-cyclodextrin-grafted polyethylenimine hydrogels for drug delivery. J Appl Polym Sci. 2008;108:3031–3037. doi: 10.1002/app.27931. [DOI] [Google Scholar]
  151. Zhang D, Lv P, Zhou C, Zhao Y, Liao X, Yang B. Cyclodextrin-based delivery systems for cancer treatment. Mater Sci Eng C. 2019;96:872–886. doi: 10.1016/j.msec.2018.11.031. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Chemistry Letters are provided here courtesy of Nature Publishing Group

RESOURCES